 NEW YORK--BUSINESS WIRE--WaterMill Asset Management Corp. together with its affiliates, WaterMill or we, which collectively with the other participants in its consent solicitation beneficially owns approximately 3.3 of the outstanding shares of Ziopharm Oncology, Inc. NASDAQ: ZIOP Ziopharm or the Company, today responded to the low-road campaign that the incumbent Board of Directors the Board has apparently initiated in order to smear Holger Weis and misrepresent his more t 